series-c-plus
Stage
2
Investors
About
Castle Creek Biosciences is a cell and gene therapy company developing novel gene therapies to treat patients with genetic diseases, including conducting a registrational Phase 3 trial for dystrophic epidermolysis bullosa (DEB).
Explore Castle Creek Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.